{"id":"https://openalex.org/W2005274511","doi":"https://doi.org/10.2165/00003495-200060001-00002","title":"Epidermal Growth Factor Receptor Tyrosine Kinase as a Target for Anticancer Therapy","display_name":"Epidermal Growth Factor Receptor Tyrosine Kinase as a Target for Anticancer Therapy","alternate_titles":[],"publication_year":2000,"publication_date":"2000-01-01","ids":{"openalex":"https://openalex.org/W2005274511","doi":"https://doi.org/10.2165/00003495-200060001-00002","mag":"2005274511","pmid":"https://pubmed.ncbi.nlm.nih.gov/11129168"},"language":"en","primary_location":{"id":"doi:10.2165/00003495-200060001-00002","doi":"https://doi.org/10.2165/00003495-200060001-00002","is_oa":false,"landing_page_url":"https://doi.org/10.2165/00003495-200060001-00002","pdf_url":null,"source":{"id":"https://openalex.org/S4436492","display_name":"Drugs","issn_l":"0012-6667","issn":["0012-6667","1179-1950"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drugs","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2005274511"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5013952219","display_name":"\u00c9ric Raymond","orcid":"https://orcid.org/0000-0001-5491-2708","observed_orcids":["https://orcid.org/0000-0001-5491-2708"]},"institutions":[{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Eric Raymond","raw_affiliation_strings":["Department of Medicine, Institute Gustave-Roussy, Villejuif, France. raymond@igr.fr","Department of Medicine, Institute Gustave-Roussy, Villejuif-Cedex, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Institute Gustave-Roussy, Villejuif, France. raymond@igr.fr","institution_ids":["https://openalex.org/I2801843802"]},{"raw_affiliation_string":"Department of Medicine, Institute Gustave-Roussy, Villejuif-Cedex, France","institution_ids":["https://openalex.org/I2801843802"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002864173","display_name":"Sandrine J. Faivre","orcid":"https://orcid.org/0000-0002-1590-485X","observed_orcids":["https://orcid.org/0000-0002-1590-485X"]},"institutions":[{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Sandrine Faivre","raw_affiliation_strings":["Department of Medicine, Institute Gustave-Roussy, 39 rue Camille Desmoulins, 94815, Villejuif-Cedex, France","Department of Medicine, Institute Gustave-Roussy, Villejuif-Cedex, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Institute Gustave-Roussy, 39 rue Camille Desmoulins, 94815, Villejuif-Cedex, France","institution_ids":["https://openalex.org/I2801843802"]},{"raw_affiliation_string":"Department of Medicine, Institute Gustave-Roussy, Villejuif-Cedex, France","institution_ids":["https://openalex.org/I2801843802"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5103498511","display_name":"Jean Pierre Armand","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Jean Pierre Armand","raw_affiliation_strings":["Department of Medicine, Institute Gustave-Roussy, 39 rue Camille Desmoulins, 94815, Villejuif-Cedex, France","Department of Medicine, Institute Gustave-Roussy, Villejuif-Cedex, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Institute Gustave-Roussy, 39 rue Camille Desmoulins, 94815, Villejuif-Cedex, France","institution_ids":["https://openalex.org/I2801843802"]},{"raw_affiliation_string":"Department of Medicine, Institute Gustave-Roussy, Villejuif-Cedex, France","institution_ids":["https://openalex.org/I2801843802"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5013952219"],"corresponding_institution_ids":["https://openalex.org/I2801843802"],"apc_list":{"value":5990,"currency":"USD","value_usd":5990},"apc_paid":null,"fwci":2.3721,"has_fulltext":false,"cited_by_count":439,"citation_normalized_percentile":{"value":0.91542289,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":97,"max":100},"biblio":{"volume":"60","issue":"Supplement 1","first_page":"15","last_page":"23"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.004000000189989805,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13779","display_name":"Cancer Mechanisms and Therapy","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/epidermal-growth-factor-receptor","display_name":"epidermal growth factor receptor","score":0.9990000128746033},{"id":"https://openalex.org/keywords/egfr-tyrosine-kinase-inhibitors","display_name":"EGFR tyrosine kinase inhibitors","score":0.9490000009536743},{"id":"https://openalex.org/keywords/targeted-cancer-therapy","display_name":"targeted cancer therapy","score":0.6990000009536743},{"id":"https://openalex.org/keywords/monoclonal-antibodies","display_name":"monoclonal antibodies","score":0.8399999737739563},{"id":"https://openalex.org/keywords/trastuzumab","display_name":"trastuzumab","score":0.9110000133514404},{"id":"https://openalex.org/keywords/cetuximab","display_name":"cetuximab","score":1.0},{"id":"https://openalex.org/keywords/gefitinib","display_name":"gefitinib","score":0.8840000033378601},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.4410000145435333},{"id":"https://openalex.org/keywords/angiogenesis","display_name":"angiogenesis","score":0.6380000114440918},{"id":"https://openalex.org/keywords/cell-invasion","display_name":"cell invasion","score":0.40799999237060547},{"id":"https://openalex.org/keywords/cell-motility","display_name":"cell motility","score":0.5120000243186951}],"concepts":[{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.6818380355834961},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.607807993888855},{"id":"https://openalex.org/C101544691","wikidata":"https://www.wikidata.org/wiki/Q420511","display_name":"Receptor tyrosine kinase","level":3,"score":0.5697367191314697},{"id":"https://openalex.org/C180361614","wikidata":"https://www.wikidata.org/wiki/Q7202242","display_name":"Platelet-derived growth factor receptor","level":4,"score":0.4987051486968994},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.4973903000354767},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.4588703513145447},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.45616820454597473},{"id":"https://openalex.org/C23440912","wikidata":"https://www.wikidata.org/wiki/Q18030230","display_name":"ROR1","level":5,"score":0.44141197204589844},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.41166555881500244},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.34340065717697144},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.24839907884597778},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.23435547947883606},{"id":"https://openalex.org/C2775960820","wikidata":"https://www.wikidata.org/wiki/Q408378","display_name":"Growth factor","level":3,"score":0.15947967767715454}],"mesh":[{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D002455","descriptor_name":"Cell Division","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D002471","descriptor_name":"Cell Transformation, Neoplastic","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008024","descriptor_name":"Ligands","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015398","descriptor_name":"Signal Transduction","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D015398","descriptor_name":"Signal Transduction","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D066246","descriptor_name":"ErbB Receptors","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D066246","descriptor_name":"ErbB Receptors","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.2165/00003495-200060001-00002","doi":"https://doi.org/10.2165/00003495-200060001-00002","is_oa":false,"landing_page_url":"https://doi.org/10.2165/00003495-200060001-00002","pdf_url":null,"source":{"id":"https://openalex.org/S4436492","display_name":"Drugs","issn_l":"0012-6667","issn":["0012-6667","1179-1950"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drugs","raw_type":"journal-article"},{"id":"pmid:11129168","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11129168","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drugs","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9476000070571899,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":31,"referenced_works":["https://openalex.org/W26155307","https://openalex.org/W127411600","https://openalex.org/W141627170","https://openalex.org/W1592467150","https://openalex.org/W1779286308","https://openalex.org/W1832198125","https://openalex.org/W1913061990","https://openalex.org/W1954313480","https://openalex.org/W1966801789","https://openalex.org/W1970901225","https://openalex.org/W1986727868","https://openalex.org/W2003418168","https://openalex.org/W2008294759","https://openalex.org/W2010174111","https://openalex.org/W2011869270","https://openalex.org/W2029548655","https://openalex.org/W2038882649","https://openalex.org/W2041456547","https://openalex.org/W2045406970","https://openalex.org/W2047950905","https://openalex.org/W2049938167","https://openalex.org/W2072218566","https://openalex.org/W2081625464","https://openalex.org/W2085141824","https://openalex.org/W2109960839","https://openalex.org/W2147582324","https://openalex.org/W2165525481","https://openalex.org/W2165633855","https://openalex.org/W2395521642","https://openalex.org/W4244120980","https://openalex.org/W4301762603"],"related_works":["https://openalex.org/W26155307","https://openalex.org/W2008631520","https://openalex.org/W2039633811","https://openalex.org/W2133293909","https://openalex.org/W2110872512","https://openalex.org/W2160425081","https://openalex.org/W2053078719","https://openalex.org/W2929670959","https://openalex.org/W2022039302","https://openalex.org/W4223444467"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2005274511","counts_by_year":[{"year":2026,"cited_by_count":7},{"year":2025,"cited_by_count":6},{"year":2024,"cited_by_count":9},{"year":2023,"cited_by_count":17},{"year":2022,"cited_by_count":18},{"year":2021,"cited_by_count":16},{"year":2020,"cited_by_count":13},{"year":2019,"cited_by_count":14},{"year":2018,"cited_by_count":14},{"year":2017,"cited_by_count":14},{"year":2016,"cited_by_count":13},{"year":2015,"cited_by_count":21},{"year":2014,"cited_by_count":22},{"year":2013,"cited_by_count":19},{"year":2012,"cited_by_count":19}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
